Pale Fire Capital SE
PALI icon

Pale Fire Capital SE’s Palisade Bio PALI Stock Holding History

Pale Fire Capital SE’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$150K Hold
111,410
– – 0.01% 53
2026
Q2 		$233K Hold
111,410
– – 0.02% 61
2026
Q1 		$195K Buy
111,410
+40,700
+58% +$74K 0.02% 56
2025
Q4 		$166K Buy
+70,710
New +$136K 0.01% 56

Other funds holding PALI

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Silverarc Capital Management
Silverarc Capital Management Boston, Massachusetts $854M AUM 179.73% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Propel Bio Management
Propel Bio Management Los Angeles, California $189M AUM 71.31% 1-Year Est. Return
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $29.2B AUM 33.64% 1-Year Est. Return

Pale Fire Capital SE's PALI Position: Q3 2026 in Review

Pale Fire Capital SE held its Palisade Bio (PALI) position steady in Q3 2026 at 111,410 shares worth $150K. The position accounts for 0.01% of the portfolio, ranked #53.

Pale Fire Capital SE first reported a position in PALI in Q4 2025 and has held it in 4 quarters since. The position peaked at $233K in Q2 2026. 71 funds tracked by Wall St. Rank hold PALI as of Q3 2026.

  • Pale Fire Capital SE held 111,410 shares of Palisade Bio worth $150K as of Q3 2026.
  • Pale Fire Capital SE left its Palisade Bio share count unchanged in Q3 2026.
  • Palisade Bio made up 0.01% of Pale Fire Capital SE's portfolio in Q3 2026, its #53 holding.
  • Pale Fire Capital SE first reported a position in Palisade Bio in Q4 2025 and has held it in 4 quarters since.
  • Pale Fire Capital SE's Palisade Bio position peaked at $233K in Q2 2026.
  • 71 funds tracked by Wall St. Rank held Palisade Bio as of Q3 2026.

Based on Pale Fire Capital SE's 13F filing for Q3 2026, filed 13 Nov 2026.